ATE355061T1 - Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen - Google Patents

Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen

Info

Publication number
ATE355061T1
ATE355061T1 AT03757468T AT03757468T ATE355061T1 AT E355061 T1 ATE355061 T1 AT E355061T1 AT 03757468 T AT03757468 T AT 03757468T AT 03757468 T AT03757468 T AT 03757468T AT E355061 T1 ATE355061 T1 AT E355061T1
Authority
AT
Austria
Prior art keywords
transdermal delivery
delivery device
active component
misuse
contained
Prior art date
Application number
AT03757468T
Other languages
German (de)
English (en)
Inventor
Carl J Baker
Ihor Shevchuk
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE355061T1 publication Critical patent/ATE355061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/70—Chemical treatment, e.g. pH adjustment or oxidation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Processing Of Solid Wastes (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT03757468T 2002-06-10 2003-06-10 Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen ATE355061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38780002P 2002-06-10 2002-06-10

Publications (1)

Publication Number Publication Date
ATE355061T1 true ATE355061T1 (de) 2006-03-15

Family

ID=29736367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03757468T ATE355061T1 (de) 2002-06-10 2003-06-10 Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen

Country Status (22)

Country Link
US (2) US20040033255A1 (OSRAM)
EP (4) EP1837023A1 (OSRAM)
JP (3) JP4949625B2 (OSRAM)
KR (2) KR20110120358A (OSRAM)
CN (2) CN100525767C (OSRAM)
AT (1) ATE355061T1 (OSRAM)
AU (2) AU2003251482A1 (OSRAM)
CA (1) CA2488915C (OSRAM)
CY (1) CY1107630T1 (OSRAM)
DE (1) DE60312160T2 (OSRAM)
DK (1) DK1513532T3 (OSRAM)
EA (1) EA007240B1 (OSRAM)
ES (1) ES2283812T3 (OSRAM)
IL (1) IL165517A0 (OSRAM)
MX (1) MXPA04012333A (OSRAM)
NO (1) NO334455B1 (OSRAM)
NZ (1) NZ537180A (OSRAM)
PT (1) PT1513532E (OSRAM)
SI (1) SI1513532T1 (OSRAM)
UA (1) UA82194C2 (OSRAM)
WO (1) WO2003103673A1 (OSRAM)
ZA (1) ZA200409495B (OSRAM)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
BRPI0507210A (pt) * 2004-02-23 2007-06-12 Euro Celtique Sa dispositivo que impede o uso indevido para administração transdérmica de opióide
US20060045897A1 (en) * 2004-08-27 2006-03-02 Aso Corporation Occlusive articles for wart treatment
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006069008A1 (en) * 2004-12-22 2006-06-29 Vesta Medical, Llc Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches
US9522188B2 (en) * 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
EP2054031B1 (en) 2006-07-21 2016-04-06 BioDelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US20080226702A1 (en) * 2007-03-16 2008-09-18 Endo Pharmaceuticals, Inc. Transdermal Delivery Form Disposal Systems and Methods
WO2009106831A2 (en) 2008-02-28 2009-09-03 Syntropharma Limited Pharmaceutical composition
WO2009120889A2 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
DE202008004785U1 (de) * 2008-04-04 2009-08-13 Grünenthal GmbH Entsorgungsvorrichtung
US8329210B2 (en) * 2008-09-23 2012-12-11 Pharmapatch, Llc Twin transdermal drug delivery patch
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US8507182B2 (en) * 2009-06-09 2013-08-13 Eastman Kodak Company Method of providing lithographic printing plates
DE102009036485B4 (de) * 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
UA112411C2 (uk) 2010-03-26 2016-09-12 Філіп Морріс Продактс С.А. Пригнічення подразнення рецепторів при споживанні бездимних тютюнових виробів
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US8790583B2 (en) * 2011-09-30 2014-07-29 Teikoku Pharma Usa, Inc. Transdermal patch disposal system
BR112014005543A2 (pt) 2011-09-30 2017-03-21 Teikoku Pharma Usa Inc sistema de descarte de medicação geral
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
MX2017010675A (es) 2015-02-19 2018-11-09 Condesant Biiomedical Inc Dispositivos medicos para generar calor y metodos de tratamiento usando los mismos.
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
GB201520390D0 (en) * 2015-11-19 2016-01-06 Euro Celtique Sa Composition
US20170273974A1 (en) 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
JPWO2017164084A1 (ja) 2016-03-24 2019-02-07 株式会社 メドレックス 誤用防止特性を有する貼付製剤
CA2972220C (en) * 2016-06-29 2023-01-24 Disposerx, Inc. Disposal of medicaments
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3685859A4 (en) 2017-09-22 2021-07-07 Medrx Co., Ltd. NON-STICKABLE ADHESIVE STAMP
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
EP4403205A3 (en) * 2019-12-10 2024-08-07 Candesant Biomedical, Inc. Methods and systems for disposing alkali metal patches
EP4378432A3 (en) 2019-12-10 2024-07-31 Candesant Biomedical, Inc. Medical device for generating heat
CN119588727B (zh) * 2024-12-06 2025-09-26 奕瑞新材料科技（太仓）有限公司 一种碘化铯闪烁屏用激活剂提纯系统、提纯方法及应用

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3540580A (en) * 1967-07-03 1970-11-17 Borden Inc Heat-seal adhesive and package
US3472931A (en) 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
US3903256A (en) 1972-02-07 1975-09-02 Procter & Gamble Compositions for topical application of animal tissue and method of enhancing penetration thereof
US3896238A (en) 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4130667A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4335115A (en) 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
US4166058A (en) * 1978-08-11 1979-08-28 The Goodyear Tire & Rubber Company Heat sensitive primer exhibiting color change and containing a resin blend, elemental sulfur, and a dye
US4326566A (en) 1979-09-11 1982-04-27 N. V. Weefautomaten Picanol Color selector
US4299826A (en) 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4248748A (en) * 1980-02-04 1981-02-03 Minnesota Mining And Manufacturing Company Heat-activated adhesive
DE3047635A1 (de) * 1980-12-17 1982-07-22 Hilti AG, 9494 Schaan Klebeverfahren mittels schmelzklebstoff sowie mittel zur durchfuehrung des verfahrens
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4560553A (en) 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4510621A (en) * 1983-06-30 1985-04-09 Arvey Corporation Self-sealing pouch for forming adhesive-to-adhesive seal
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
JPS61103840A (ja) 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5066648A (en) 1985-11-29 1991-11-19 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
US4973968A (en) 1986-03-07 1990-11-27 Plessey Overseas Limited Radar system for determining first time around targets from multiple time around targets
US4863970A (en) 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4940586A (en) 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4746515A (en) 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4879275A (en) 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US5225473A (en) * 1987-11-25 1993-07-06 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesives
GB8811669D0 (en) * 1988-05-17 1988-06-22 Alcan Int Ltd Colour-changeable adhesive
US5164406A (en) 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
US5378730A (en) 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US5641504A (en) 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US4960771A (en) 1988-07-12 1990-10-02 Rajadhyaksha Vithal J Oxazolidinone penetration enhancing compounds
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5750134A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5240711A (en) 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5069909A (en) 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3196851B2 (ja) * 1991-04-01 2001-08-06 積水化学工業株式会社 医療用貼付剤
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5981666A (en) * 1991-07-12 1999-11-09 Adhesives Research, Inc. Method for the production of a high performance pressure sensitive adhesive
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
US5238933A (en) 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
CA2097163C (en) 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
US5308625A (en) 1992-09-02 1994-05-03 Cygnus Therapeutic Systems Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US6162456A (en) 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
JPH0710742Y2 (ja) * 1993-02-05 1995-03-15 日本臓器製薬株式会社 救急絆創膏
ATE163262T1 (de) * 1993-04-20 1998-03-15 Hexal Ag Wirkstoffplaster
US5520385A (en) * 1993-07-30 1996-05-28 Composite Development Corporation Article assembled with thermoreponsive material and method
ATE183926T1 (de) 1993-09-29 1999-09-15 Alza Corp Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
US5470529A (en) * 1994-03-08 1995-11-28 Sumitomo Metal Industries, Ltd. High tensile strength steel sheet having improved formability
US5420106A (en) 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
JP2819236B2 (ja) * 1994-05-06 1998-10-30 日東電工株式会社 経皮吸収製剤
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9425783D0 (en) * 1994-12-21 1995-02-22 Ethical Pharma Ltd Packaging of patches
US5573778A (en) 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5834468A (en) 1995-07-07 1998-11-10 Zeneca Limited Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
AU6657396A (en) * 1995-07-28 1997-02-26 Novartis Ag Transdermal system
US5902603A (en) 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
US5837289A (en) 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US6004578A (en) 1996-10-24 1999-12-21 Alza Corporation Permeation enhances for transdermal drug delivery compositions, devices and methods
US5952000A (en) 1996-10-30 1999-09-14 Theratech, Inc. Fatty acid esters of lactic acid salts as permeation enhancers
DE19649534B4 (de) * 1996-11-29 2004-05-06 Lts Lohmann Therapie-Systeme Ag Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5804215A (en) * 1997-03-21 1998-09-08 L. Perrigo Company Transdermal patch disposal system and method
US6017983A (en) * 1998-01-29 2000-01-25 Alpha Metals, Inc. Color indicator for completion of polymerization for thermosets
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
US7018649B2 (en) * 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
WO2002085268A1 (en) * 2001-04-23 2002-10-31 Euro-Celtique S.A. Disposal system for transdermal dosage form
ES2546828T3 (es) * 2001-05-01 2015-09-29 Euro-Celtique S.A. Sistemas transdérmicos resistentes al abuso que contienen opioides
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain

Also Published As

Publication number Publication date
AU2003251482A1 (en) 2003-12-22
CA2488915C (en) 2011-10-04
CN101455649A (zh) 2009-06-17
NZ537180A (en) 2008-03-28
JP4949625B2 (ja) 2012-06-13
CA2488915A1 (en) 2003-12-18
EP1837023A1 (en) 2007-09-26
CN1658878A (zh) 2005-08-24
EP1513532A1 (en) 2005-03-16
SI1513532T1 (sl) 2007-08-31
EP2266565A1 (en) 2010-12-29
EP2298302A1 (en) 2011-03-23
JP2011016802A (ja) 2011-01-27
DE60312160D1 (de) 2007-04-12
NO334455B1 (no) 2014-03-10
KR101407131B1 (ko) 2014-06-19
NO20050126L (no) 2005-01-10
DE60312160T2 (de) 2007-10-31
IL165517A0 (en) 2006-01-15
KR20050020977A (ko) 2005-03-04
ZA200409495B (en) 2006-05-31
JP5898242B2 (ja) 2016-04-06
JP5507367B2 (ja) 2014-05-28
ES2283812T3 (es) 2007-11-01
EP1513532B1 (en) 2007-02-28
AU2009217420A1 (en) 2009-10-15
AU2009217420B2 (en) 2013-06-13
JP2005538058A (ja) 2005-12-15
US20040033255A1 (en) 2004-02-19
WO2003103673A1 (en) 2003-12-18
CN100525767C (zh) 2009-08-12
MXPA04012333A (es) 2005-02-25
UA82194C2 (uk) 2008-03-25
EA200401564A1 (ru) 2005-08-25
PT1513532E (pt) 2007-05-31
JP2014088422A (ja) 2014-05-15
CY1107630T1 (el) 2013-04-18
CN101455649B (zh) 2014-02-26
US20080274168A1 (en) 2008-11-06
KR20110120358A (ko) 2011-11-03
DK1513532T3 (da) 2007-07-02
EA007240B1 (ru) 2006-08-25

Similar Documents

Publication Publication Date Title
ATE355061T1 (de) Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen
ATE459380T1 (de) Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren
WO2004039427A3 (en) Transdermal delivery system for anti-emetic medication
WO2003096726A3 (en) Method and apparatus for use in securing an electronic device such as a cell phone
ATE460437T1 (de) Polymere von fluormonomeren und hydrophilen monomeren
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
WO2006041911A3 (en) Device transdermal administration of drugs including acrylic polymers
ATE317711T1 (de) Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten
WO2007146231A3 (en) Solvent systems for coating medical devices
BRPI0518909A2 (pt) mÉtodo e aparelho para ativar/desativar dinamicamente um sistema operacional
DK1121111T3 (da) Forbindelser til behandling af vægttab
WO2005026878A3 (en) Methods and apparatus for content protection in a wireless network
DK1957130T3 (da) Hydrofilt overtræk omfattende en polyelektrolyt
EP1108770A3 (en) Removable pressure-sensitive adhesive sheet
WO2006037049A3 (en) Application of a coating on a medical device
DE60332750D1 (en) Hydrogel
DK0781122T3 (da) Matrix til transdermal lægmiddelafgivelse
WO2005051456A3 (en) Composition and apparatus for transdermal delivery
WO2006083628A3 (en) Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species
WO2007126519A3 (en) System, method, and apparatus to enable backup wireless devices
EP1282028A3 (en) Method and apparatus for locking an application within a trusted computing environment
CA2806183A1 (en) Transdermal adhesive compositions, devices, and methods
WO2002075527A3 (en) Dynamically downloading and executing system services on a wireless device
WO2008115811A3 (en) Transdermal delivery form disposal systems and methods
ATE279984T1 (de) Komplexierungstruktur, vorrichtung und verfahren zur behandlung von abwässern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1513532

Country of ref document: EP